157 related articles for article (PubMed ID: 10850423)
1. Loss of p53 in benzene-induced thymic lymphomas in p53+/- mice: evidence of chromosomal recombination.
Boley SE; Anderson EE; French JE; Donehower LA; Walker DB; Recio L
Cancer Res; 2000 Jun; 60(11):2831-5. PubMed ID: 10850423
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of aberrant Y chromosomes in gamma-ray-induced thymic lymphomas lacking p53.
Chou D; Matsuki J; Saitou Y; Kosugi SI; Shinbo T; Gejyo F; Niwa O; Kominami R
Mol Carcinog; 1999 Nov; 26(3):157-62. PubMed ID: 10559790
[TBL] [Abstract][Full Text] [Related]
3. Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas.
Kakinuma S; Nishimura M; Kubo A; Nagai JY; Amasaki Y; Majima HJ; Sado T; Shimada Y
Mutat Res; 2005 May; 572(1-2):132-41. PubMed ID: 15790496
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ
Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic and cellular events during radiation-induced thymic lymphomagenesis in the p53 heterozygous (+/-) B10 mouse.
Tanaka K; Watanabe K; Mori M; Kamisaku H; Tsuji H; Hirabayashi Y; Inoue T; Yoshida K; Aizawa S
Int J Radiat Biol; 2002 Mar; 78(3):165-72. PubMed ID: 11869471
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice.
Hulla JE; French JE; Dunnick JK
Carcinogenesis; 2001 Jan; 22(1):89-98. PubMed ID: 11159746
[TBL] [Abstract][Full Text] [Related]
7. Allelic loss analysis of gamma-ray-induced mouse thymic lymphomas: two candidate tumor suppressor gene loci on chromosomes 12 and 16.
Matsumoto Y; Kosugi S; Shinbo T; Chou D; Ohashi M; Wakabayashi Y; Sakai K; Okumoto M; Mori N; Aizawa S; Niwa O; Kominami R
Oncogene; 1998 May; 16(21):2747-54. PubMed ID: 9652741
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of human O6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in heterozygous p53 deficient mice.
Reese JS; Allay E; Gerson SL
Oncogene; 2001 Aug; 20(38):5258-63. PubMed ID: 11536039
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 11 loss from thymic lymphomas induced in heterozygous Trp53 mice by phenolphthalein.
Hulla JE; French JE; Dunnick JK
Toxicol Sci; 2001 Apr; 60(2):264-70. PubMed ID: 11248138
[TBL] [Abstract][Full Text] [Related]
10. Radiation-associated loss of heterozygosity at the Znfn1a1 (Ikaros) locus on chromosome 11 in murine thymic lymphomas.
Shimada Y; Nishimura M; Kakinuma S; Okumoto M; Shiroishi T; Clifton KH; Wakana S
Radiat Res; 2000 Sep; 154(3):293-300. PubMed ID: 10956435
[TBL] [Abstract][Full Text] [Related]
11. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
Baxter EW; Blyth K; Cameron ER; Neil JC
J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss mapping and physical delineation of a region harboring a putative thymic lymphoma suppressor gene on mouse chromosome 12.
Shinbo T; Matsuki A; Matsumoto Y; Kosugi S; Takahashi Y; Niwa O; Kominami R
Oncogene; 1999 Jul; 18(28):4131-6. PubMed ID: 10435594
[TBL] [Abstract][Full Text] [Related]
13. Allelotype analysis of 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
Zhuang SM; Eklund LK; Cochran C; Rao GN; Wiseman RW; Söderkvist P
Cancer Res; 1996 Jul; 56(14):3338-43. PubMed ID: 8764131
[TBL] [Abstract][Full Text] [Related]
14. Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53/Big Blue double transgenic mice.
Buettner VL; Hill KA; Nishino H; Schaid DJ; Frisk CS; Sommer SS
Oncogene; 1996 Dec; 13(11):2407-13. PubMed ID: 8957082
[TBL] [Abstract][Full Text] [Related]
15. Allelic losses on chromosome 4 suggest the existence of a candidate tumor suppressor gene region of about 0.6 cM in gamma-radiation-induced mouse primary thymic lymphomas.
Santos J; Pérez de Castro I; Herranz M; Pellicer A; Fernández-Piqueras J
Oncogene; 1996 Feb; 12(3):669-76. PubMed ID: 8637724
[TBL] [Abstract][Full Text] [Related]
16. Distinct structural abnormalities of chromosomes 11 and 12 associated with loss of heterozygosity in X-ray-induced mouse thymic lymphomas.
Yoshida MA; Nakata A; Akiyama M; Kakinuma S; Sado T; Nishimura M; Shimada Y
Cancer Genet Cytogenet; 2007 Nov; 179(1):1-10. PubMed ID: 17981208
[TBL] [Abstract][Full Text] [Related]
17. Hprt mutant frequency and p53 gene status in mice chronically exposed by inhalation to benzene.
Albertini RJ; Judice SA; Recio L; Walker VE
Chem Biol Interact; 2010 Mar; 184(1-2):77-85. PubMed ID: 20035728
[TBL] [Abstract][Full Text] [Related]
18. Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.
Tsuji H; Ishii-Ohba H; Katsube T; Ukai H; Aizawa S; Doi M; Hioki K; Ogiu T
Cancer Res; 2004 Dec; 64(24):8882-90. PubMed ID: 15604248
[TBL] [Abstract][Full Text] [Related]
19. V(D)J recombination is not required for the development of lymphoma in p53-deficient mice.
Nacht M; Jacks T
Cell Growth Differ; 1998 Feb; 9(2):131-8. PubMed ID: 9486849
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
French JE; Lacks GD; Trempus C; Dunnick JK; Foley J; Mahler J; Tice RR; Tennant RW
Carcinogenesis; 2001 Jan; 22(1):99-106. PubMed ID: 11159747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
